
Type IV myocardial infarction associated with acute stent thrombosis in the early period after revascularization in a patient with new coronavirus infection COVID-19
Author(s) -
В Н Ардашев,
A. V. Nagovitsyn,
Narek Zakaryan,
O. P. Donetskaya,
G. E. Kubenskiy,
Е. Б. Молохоев,
A. H. Davtyan,
K. V. Leushina,
А. С. Панков,
D. V. Grachev
Publication year - 2021
Publication title -
kliničeskaâ medicina
Language(s) - English
Resource type - Journals
eISSN - 2412-1339
pISSN - 0023-2149
DOI - 10.30629/0023-2149-2021-99-5-6-369-374
Subject(s) - medicine , myocardial infarction , cardiology , thrombosis , covid-19 , myocarditis , viral myocarditis , coronavirus , disease , infectious disease (medical specialty)
New facts suggest that COVID-19 coronavirus infection is partly mediated by hypercoagulability reactions characterized by micro- and macrovascular thrombotic angiopathy, which leads to acute myocardial injury, myocarditis, arrhythmias and numerous cases of pulmonary thromboembolic disease . The article presents a clinical observation of acute myocardial infarction development as a result of early thrombosis of an implanted coronary stent in a patient diagnosed with a new coronavirus infection COVID-19.